Parameters | Non-CAD | CAD | P |
---|---|---|---|
n (male/female) | 84 (43/41) | 228 (163/65) | 0.001 |
Age, years | 64.0 ± 9.9 | 67.0 ± 10.0 | 0.018 |
Body mass index, kg/m2 | 24.8 ± 3.9 | 24.5 ± 3.0 | 0.520 |
Waist circumference, cm | 89.6 ± 10.9 | 90.6 ±8.9 | 0.408 |
Fasting plasma glucose, mmol/L | 5.5 (5.0, 6.0) | 5.5 (5.0, 6.4) | 0.448 |
2h postprandial glucose, mmol/L | 8.2 (6.2, 9.8) | 8.8 (6.7, 12.4) | 0.031 |
Glycated hemoglobin A1c, % | 6.0 (5.6, 6.5) | 6.2 (5.8, 6.9) | 0.005 |
Fasting insulin, mU/L | 16.3(11.9, 22.2) | 16.5 (12.0, 24.5) | 0.431 |
HOMA-IR | 4.0 (2.8, 6.0) | 4.0(2.8, 5.9) | 0.939 |
Systolic blood pressure, mmHg | 130.0 (120.0, 150.0) | 130 (120.0, 150.0) | 0.335 |
Diastolic blood pressure, mmHg | 80.0 (70.0, 85.8) | 80.0 (70.0, 83.8) | 0.569 |
Total cholesterol, mmol/L | 4.5 ± 1.1 | 4.3 ± 1.1 | 0.070 |
Triglyceride, mmol/L | 1.5 (1.0, 2.2) | 1.5 (1.1, 2.2) | 0.461 |
HDL-c, mmol/L | 1.2 ± 0.3 | 1.1 ± 0.3 | 0.018 |
LDL-c, mmol/L | 3.1 ± 0.9 | 2.9 ± 1.0 | 0.221 |
C-reactive protein, mg/L | 1.4 (0.6, 3.6) | 1.4 (0.6, 4.0) | 0.329 |
Adiponectin, μg/mL | 8.4 (5.6, 11,9) | 7.1 (4.7, 12.1) | 0.113 |
Serum creatinine, μmol/L | 72.0 (61.0, 87.3) | 79.0 (68.0, 91.0) | 0.008 |
Uric acid, μmol/L | 324.4 ± 85.5 | 352.3 ± 90.6 | 0.392 |
eGFR, mL/min/1.73m2 | 90.7 ± 25.1 | 85.5 ± 23.2 | 0.092 |
24h urine albumin, mg/d | 7.5 (5.1, 14.1) | 7.1 (4.9, 18.3) | 0.775 |
CAD family history, n (%) | 35 (41.6) | 106 (46.5) | 0.243 |
Smoking, n (%) | 31 (36.9) | 107 (46.9) | 0.073 |
Metabolic syndrome, n (%) | 51 (60.7) | 146 (64.0) | 0.340 |
Central obesity, n (%) | 46 (56.1) | 132 (58.9) | 0.376 |
Hyperglycemia, n (%) | 51 (60.7) | 147 (64.5) | 0.314 |
Hypertension, n (%) | 71 (84.5) | 206 (90.4) | 0.109 |
Hypertriglyceridemia, n (%) | 34 (40.5) | 89 (39.0) | 0.458 |
Low HDL-c, n (%) | 33 (39.3) | 117 (51.3) | 0.039 |
Hypoglycemic therapy, n (%) | 12 (14.3) | 60 (26.3) | 0.016 |
Anti-hypertensive therapy, n (%) | 54 (64.3) | 166 (72.8) | 0.094 |
Lipid-lowering therapy, n (%) | 11 (13.1) | 80 (35.1) | <0.001 |